In vitro preclinical models for a rational design of chemotherapy combinations in human tumors (Q34133637)

31 July 2017

1 reference

title

In vitro preclinical models for a rational design of chemotherapy combinations in human tumors (English)

1 reference

31 July 2017

1 reference

Zoli W

1

1 reference

31 July 2017

Ricotti L

2

1 reference

31 July 2017

Tesei A

3

1 reference

31 July 2017

Barzanti F

4

1 reference

31 July 2017

Amadori D

5

1 reference

31 July 2017

1 January 2001

1 reference

Critical Reviews in Oncology Hematology

31 July 2017

1 reference

31 July 2017

37

1 reference

31 July 2017

1

1 reference

31 July 2017

69-82

1 reference

The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and Sulfides

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Considerations in the use of nude mice for cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

The use of animal models in cancer drug discovery and development

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Individualizing chemotherapy for solid tumors--is there any alternative?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

A critical appraisal of the "human tumor stem-cell assay".

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Chemosensitivity testing: another chapter

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

He's not going to talk about in vitro predictive assays again, is he?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

In vitro drug sensitivity testing for the individual patient: an ideal adjunct to current methods of treatment choice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Primary Bioassay of Human Tumor Stem Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

In vitro testing of chemotherapeutic combinations in a rapid thymidine incorporation assay

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Estimation of differential in vitro sensitivity of non-hodgkin lymphomas to anticancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Modification of the DiSC assay by the incorporation of monoclonal antibody staining

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

New colorimetric cytotoxicity assay for anticancer-drug screening

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Review of the efficacy of individualized chemotherapy selected by in vitro drug sensitivity testing for patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Relation of cellular drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Multiple basis of combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Criteria for analyzing interactions between biologically active agents

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

A general formulation of the concept of independent action for the combined effects of agents.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

In vitro schedule-dependent interaction between paclitaxel and cisplatin in human carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Combination effects of cisplatin, vinorelbine and irinotecan in non-small-cell lung cancer cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Gemcitabine-cisplatin: a schedule finding study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

In vitro and in vivo interaction between cisplatin and topotecan in ovarian carcinoma systems

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Schedule-dependent antagonism of paclitaxel and cisplatin in human gastric and ovarian carcinoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Sequence-dependent antagonism between fluorouracil and paclitaxel in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Activity- and schedule-dependent interactions of paclitaxel, etoposide and hydroperoxy-ifosfamide in cisplatin-sensitive and -refractory human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Sequence-dependent cytotoxicity of etoposide and paclitaxel in human breast and lung cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Three-dimensional cell cultures: from molecular mechanisms to clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Multicellular spheroids as an in vitro tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Three-dimensional spheroid model in tumor biology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Multicellular spheroids: a three-dimensional in vitro culture system to study tumour biology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Formation and growth of multicellular spheroids of human origin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Evaluation of the growth rate of MCF-7 breast cancer multicellular spheroids using three mathematical models.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Study of the effects of dispase in the chemotherapy of multicellular tumour spheroids of small-cell lung carcinoma in man

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

[Treosulfan displays cytotoxic effect on spheroids of primary cell cultures of renal cell carcinoma independent of p-glycoprotein expression]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Multicellular tumor spheroids grown from pancreatic carcinoma cell lines: use as an orthotopic xenograft in athymic nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Evaluation of Taxol in head and neck squamous carcinoma multicellular tumor spheroids.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Cytometry of cyclin proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Cell-cycle analysis in 20 minutes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Clinical evaluation for the mechanism of cisplatin with bromodeoxyuridine by flow cytometry and clinico-histological study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Docetaxel and gemcitabine activity in NSCLC cell lines and in primary cultures from human lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Lonidamine as a modulator of taxol activity in human ovarian cancer cells: effects on cell cycle and induction of apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Measuring the complexity of cell cycle arrest and killing of drugs: kinetics of phase-specific effects induced by taxol

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Apoptosis. Its significance in cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Major DNA fragmentation is a late event in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Inactivation of Bcl-2 by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Lonidamine significantly increases the activity of epirubicin in patients with advanced breast cancer: results from a multicenter prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900110-4

7 January 2021

10.1016/S1040-8428(00)00110-4

Identifiers

DOI

1 reference

31 July 2017

1 reference